RegeneRx Biopharmaceuticals, Inc. (RGRX)
OTCMKTS · Delayed Price · Currency is USD
0.1370
0.00 (0.00%)
Aug 13, 2025, 12:33 PM EDT
RGRX Market Cap
RGRX has a market cap or net worth of $182.54 thousand as of August 13, 2025. Its market cap has decreased by -99.08% in one year.
Market Cap
182.54K
Enterprise Value
n/a
Revenue
76.76K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.14
Market Cap Chart
Since June 16, 1987, RGRX's market cap has decreased from 58.65M to 182.54K, a decrease of -99.69%. That is a compound annual growth rate of -14.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 182.54K | 8,542.99% |
| Dec 26, 2024 | 2.11K | 16.69% |
| Dec 29, 2023 | 1.81K | -99.99% |
| Dec 30, 2022 | 19.94M | -13.19% |
| Dec 31, 2021 | 22.97M | -61.32% |
| Dec 31, 2020 | 59.38M | 222.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 561.16M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 360.45M |
| CytoDyn | 300.75M |